353
Participants
Start Date
April 30, 2013
Primary Completion Date
May 16, 2023
Study Completion Date
May 16, 2023
Epigallocatechin Gallate (EGCG)
EGCG 600 mg per day will be provided to the test group.Four capsules will be taken daily (2# bid) by the test individuals.
Placebo
Placebo qd (2# bid) for 3 years
Taiwan Cooperative Oncology Group, National Health Research Institutes, Zhunan
Mackay Memorial Hospital
OTHER
Taichung Veterans General Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Chang Gung Memorial Hospital
OTHER
China Medical University Hospital
OTHER
National Taiwan University Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER